全球切片检查钳和息肉切除勒除器市场：市场规模、份额和趋势分析（2026-2032 年）

预计到2025年，全球切片检查钳和息肉切除勒除器市场规模约为4.72亿美元。预计到2032年，该市场将以2.3%的复合年增长率成长，达到5.53亿美元以上。

本报告涵盖切片检查钳和息肉切除勒除器，它们用于胃肠内视镜检查中的组织取样和息肉切除术。报告量化了销售量、平均售价 (ASP)、市场价值、成长率和企业市场占有率。此外，报告还分析了市场驱动因素、限制因素、近期併购活动和技术趋势。报告提供了 2022 年至 2024 年的历史数据以及至 2032 年的预测数据。

这份研究报告反映了一次性器械的日益普及、结直肠癌筛检计划的扩大以及手术程序向冷勒除器转变，正在如何塑造全球切片检查钳和息肉切除勒除器市场。

市场概览

切片检查钳和息肉切除勒除器是胃肠内视镜检查中最常用的附件之一，在诊断和切除胃肠道病变、息肉和异常组织方面发挥着至关重要的作用。

过去十年，受技术进步、监管政策更新和全球健康趋势的推动，该市场发生了显着变化。儘管销售量大幅成长，但由于医院和门诊内视镜中心纷纷采用经济实惠的一次性产品，价格竞争仍面临压力。

几年前价格大幅下跌后，切片检查钳市场销售强劲反弹。一次性器械价格亲民，刺激了使用量的成长，从而支撑了市场规模，但也降低了製造商的利润率。到了2025年，价格下跌趋势趋于平缓，更稳定的定价环境带来持续的收入成长。

同时，息肉切除勒除器部分也受益于临床上越来越偏好使用冷勒除器切除小息肉，这一趋势正在增强对勒除器的需求，尤其是在全球结直肠癌筛检计画扩大的情况下。

随着手术量的增加、器械使用模式向一次性使用模式转变，以及培训水准的提高使全球医生更容易掌握先进的息肉切除技术，复杂的市场格局仍在不断演变。儘管价格竞争和可重复使用器械普及率的下降抑制了整体市场成长，但预计到2032年，该市场将保持温和、持续的成长。

市场驱动因素

抛弃式镊子

抛弃式切片检查钳已成为大多数医疗机构的首选。先前价格大幅下降后，抛弃式活检钳在医院和诊所越来越常见。其低廉的价格促使其在全球范围内的使用量和销量不断增长。

儘管价格下跌挤压了製造商的净利率，但手术量的成长仍然是总收入的主要驱动力。预计未来几年价格只会小幅下降，因此销量仍将是市场成长的主要动力。此外，某些地区限制使用可重复使用器械的法规和感染控制措施也推动了抛弃式的稳定普及。

由于製造商专注于提高设计可靠性和最先进的钳口机制，抛弃式钳市场预计将继续主导全球切片检查钳市场。

增加大肠直肠癌筛检

大肠镜检查仍然是全球最常见的内视镜检查之一。截至2025年，全球范围内促进大肠直肠癌早期发现的努力已显着扩大，尤其是在北美、欧洲和亚太部分地区。

筛检项目的参与度提高直接增加了切片检查和息肉切除术的数量，从而推高了对活检钳和勒除器的需求。许多已开发地区的人口老化进一步加剧了这一趋势，因为老年人是结直肠癌的高风险族群。

随着持续进行的意识提升宣传活动以及将筛检纳入国家健康指南，大肠直肠癌预防已成为一项重要的公共卫生优先事项。因此，预计在预测期内，对切片检查钳和息肉切除勒除器等内视镜器械的需求将持续成长。

冷勒除器技术

从历史上看，8 毫米或更小的息肉都是用切片检查钳切除的，但冷圈套术（使用非电勒除器切除小息肉，勒除器清除效果更好）正在成为许多诊所的标准治疗方法。

这项技术降低了黏膜热损伤的风险，提高了切除的彻底性，并缩短了手术时间。随着其应用范围的扩大，息肉切除的需求预计将稳定成长。

手术流程的这种转变是市场成长的关键驱动因素，因为它扩大了勒除器的应用范围，不仅用于处理较大的病灶，也用于处理较小、更常见的病例。製造商们正在积极回应，设计出操控性更好、钢丝更细、形状记忆性能更强的产品，以提高手术精度。

市场限制

从镊子到勒除器的转变

冷勒除器在小型息肉切除术中的广泛应用对市场而言是一把双面刃。虽然它促进了勒除器的需求，但也导致某些适应症下切片检查钳的使用量下降。随着医生越来越倾向于使用勒除器进行完整切除，活检钳在这些小型息肉病例中的使用率持续下降。

这种趋势在临床指引推荐使用冷勒除器而非切片检查切除小型息肉的国家尤为明显。预计从长远来看，这种转变将抑制切片检查钳领域的成长潜力。

技术挑战

儘管勒除器具有临床优势，但其操作难度高于钳取息肉。位于肠壁附近的扁平或无蒂息肉难以捕获，且切除息肉的成功回收率也参差不齐。这凸显了持续培训和改进勒除器设计的必要性。

虽然经验丰富的内视镜医师可以克服这些挑战，但它们仍然是该手术更广泛采用的限制因素，尤其是在工作人员经验不足的中心。

可重复使用设备减少

可重复使用切片检查钳的市场持续快速萎缩。这些器械比一次性器械价格更高，且若处理不当，有交叉感染的风险。多个地区的监管措施正在加速这一转变。例如，英国已实施相关法规，禁止在临床环境中使用可重复使用的活检钳。

这种转变抑制了整体市场价值，因为可重复使用器械的单位销售更高。目前，一次性器械占据市场主导地位，但由于其价格分布较低，儘管销量成长，但整体市场成长却受到限制。

目标市场和数据范围

定量范围

市场规模、份额和预测

成长率、销售量、平均售价

定性数据

市场成长趋势与限制因素

竞争对手分析与SWOT分析

併购、公司简介、产品系列

美国食品药物管理局召回事件与颠覆性技术发展

影响需求的疾病和手术数据概述

时期

• 基准年：2025年
• 预测：2026-2032年
• 历史资料：2022-2024年

数据来源

此外，也参考了内视镜医师、产业专家和市场主管的初步访谈、医院采购资料、进出口资料库和 iData Research 内部资料库。

方法

收入预测模型为销售量乘以平均售价，并根据区域手术量、利用模式和更换週期检验。

目标市场及区隔

• 切片检查钳和息肉切除勒除器市场进一步细分如下：

切片检查钳

息肉切除

竞争分析

波士顿科学公司是市场领导，预计到2025年将占据全球切片检查钳和息肉切除勒除器市场近一半的份额。该公司的成功主要归功于其Radial Jaw产品线的强大实力，该产品线是全球应用最广泛的活检钳系列之一。波士顿科学公司透过持续投资产品创新和建立全球分销网络，巩固了其在多个地区的领先地位。

奥林巴斯公司凭藉其可重复使用的切片检查钳和勒除器产品组合保持着一定的市场份额。然而，随着市场对可重复使用切片检查钳的需求持续下降，奥林巴斯近年来市占率逐渐下滑。在欧洲和部分亚洲国家等仍偏好可重复使用器械的市场，奥林巴斯仍保持着较强的竞争力。

库克医疗是全球市场第三大竞争对手。该公司提供全系列产品，包括Captura Pro活检钳、Captura一次性热活检钳和Captura迷你活检钳。在勒除器领域，库克医疗销售AcuSnare息肉切除圈套器和AcuSnare鸭嘴圈套器，这两款产品以其能够捕获小型、难以切除的息肉而闻名。

总体而言，市场集中度较低，这三家製造商占据了全球销售额的大部分。规模较小的区域性公司主要在本地市场竞争，通常专注于价格具竞争力的消耗品。

科技与临床趋势

目前，在感染预防政策和降低再处理成本的推动下，使用抛弃式切片检查钳已成为全球主流做法。

由于安全性和边缘清除能力的提高，冷勒除器正逐渐取代热勒除器和镊子来切除小型息肉。

一次性仪器的设计品质不断提高，其性能可与可重复使用的仪器相媲美，而成本却低得多。

引入了符合人体工学的手柄和改进的钳口几何形状，以提高精度并减少长时间手术过程中操作者的疲劳。

随着内视镜学会推广安全切除术和冷勒除器技术，世界各地都在努力规范训练和操作流程。

有利于一次性用品和感染控制合规性的监管政策转变，持续影响医院和诊所的采购决策。

地区

本期内容涵盖全球市场，包括来自北美、欧洲、亚太地区、拉丁美洲以及中东和非洲的数据。

调查方法附录与简称

目录

图表清单

图表列表

调查方法

全球关税的影响

切片检查钳和息肉切除勒除器市场

• 执行摘要
  • 全球切片检查钳和息肉切除勒除器市场概览
  • 竞争分析
  • 流程分段
  • 市场区隔
  • 目标区域
• 介绍
• 手术次数
  • 全组织切片检查程序
  • 切片检查技术
  • 息肉切除勒除器手术
• 市场概览
  • 按细分市场
  • 按地区
• 市场分析与预测
  • 全切片检查钳和息肉切除勒除器市场
  • 切片检查钳市场
  • 息肉切除勒除器市场
• 驾驶员和约束装置
• 竞争市占率分析

简称

The global biopsy forceps and polypectomy snare market was valued at approximately $472 million in 2025. The market is expected to grow at a compound annual growth rate (CAGR) of 2.3%, reaching over $553 million by 2032.

This report covers biopsy forceps and polypectomy snares used in gastrointestinal endoscopy for tissue sampling and polyp removal. It quantifies unit sales, average selling prices (ASPs), market values, growth rates, and company shares, and analyzes market drivers, limiters, recent mergers and acquisitions, and technology trends. It provides historical data from 2022 to 2024 and forecasts to 2032.

The scope reflects how the increasing adoption of disposable devices, the expansion of colorectal cancer screening programs, and procedural shifts toward cold snaring are shaping the global biopsy forceps and polypectomy snare markets.

Market Overview

Biopsy forceps and polypectomy snares are among the most frequently used accessories in gastrointestinal endoscopy. They play an essential role in diagnosing and removing lesions, polyps, and abnormal tissue from the digestive tract.

Over the past decade, this market has experienced notable changes driven by technological evolution, regulatory updates, and global health trends. While unit volumes have expanded significantly, pricing dynamics have remained under pressure as hospitals and ambulatory endoscopy centers adopt cost-effective single-use products.

Following a sharp drop in pricing several years ago, the biopsy forceps segment saw a strong rebound in unit sales. The affordability of disposable devices encouraged more frequent use, which in turn supported total market value despite reduced margins for manufacturers. By 2025, price erosion had slowed, and a more stable pricing environment allowed for steady revenue growth.

In parallel, the polypectomy snare segment has benefited from increasing clinical preference for cold snaring in small polyp removal procedures. This trend has strengthened demand for snares, especially as global colorectal cancer screening programs expand.

The combined market continues to evolve as procedure volumes grow, device usage patterns shift toward single-use models, and training improvements make advanced polypectomy techniques more accessible to physicians worldwide. While competitive pricing and declining reusable device adoption constrain overall value growth, the market remains poised for moderate and sustained expansion through 2032.

Market Drivers

Disposable Forcep

Disposable biopsy forceps have become the preferred choice in most healthcare settings. After the steep price drop seen in earlier years, disposable forceps became much more accessible to hospitals and clinics. The lower cost continues to encourage frequent use, increasing unit volumes worldwide.

Although reduced pricing has narrowed manufacturer margins, total revenues are still rising as procedure volumes increase. With only modest price declines projected over the coming years, unit sales will remain the main contributor to market expansion. This steady shift toward disposables has also been supported by regulatory and infection-control measures discouraging reusable device use in certain regions.

As manufacturers focus on improving design reliability and cutting-edge jaw mechanisms, the disposable segment is expected to strengthen its dominance within the global biopsy forceps market.

Increase in Colorectal Cancer Screening

Colonoscopy remains one of the highest-volume endoscopic procedures worldwide. As of 2025, global initiatives promoting early detection of colorectal cancer have expanded significantly, particularly in North America, Europe, and parts of Asia-Pacific.

Rising participation in screening programs is directly increasing the number of biopsy and polypectomy procedures, thereby boosting demand for both forceps and snares. The aging population in many developed regions is further driving this trend, as older adults represent the highest-risk group for colorectal cancer.

Ongoing awareness campaigns and the inclusion of screening in national health guidelines have made colorectal cancer prevention a key public health priority. As a result, the need for endoscopic tools such as biopsy forceps and polypectomy snares will continue to grow over the forecast period.

Cold Snaring Technique

Historically, small polyps under 8 millimeters were removed using biopsy forceps. However, the cold snaring technique, which uses a non-electrified snare to excise small polyps with better margin clearance, is becoming the standard of care in many practices.

The technique reduces the risk of thermal injury to the mucosa, improves completeness of resection, and shortens procedure time. As adoption increases, demand for polypectomy snares is expected to rise steadily.

This procedural shift represents a key driver for market growth, as it expands snare utilization beyond larger lesions into smaller, more common cases. Manufacturers are responding with product designs that offer better control, thinner wires, and improved shape memory for enhanced precision.

Market Limiters

Shift from Forceps to Snaring

The widespread adoption of cold snaring for small polyps is a double-edged factor for the market. While it benefits snare demand, it has also contributed to a decline in biopsy forceps usage for certain indications. As physicians increasingly favor snares for complete resections, forceps utilization in these smaller cases continues to fall.

This trend is particularly evident in countries where clinical guidelines recommend cold snaring over biopsy for small polyp removal. The shift is expected to constrain the growth potential of the biopsy forceps segment over time.

Technical Challenges

Despite its clinical benefits, snaring presents higher technical difficulty compared to forceps use. Flat or sessile polyps that lie close to the intestinal wall are harder to capture, and successful retrieval of resected polyps can be inconsistent. Studies have reported retrieval failure rates near 16 percent, which underscores the need for continued training and refinement of snare designs.

While experienced endoscopists can overcome these challenges, they remain a limiting factor for broader procedural adoption, particularly in facilities with less experienced staff.

Decline in Reusable Devices

The market for reusable biopsy forceps continues to decline rapidly. These instruments are more expensive than disposable versions and carry risks of cross-contamination if reprocessed improperly. Regulatory measures in several regions have accelerated this transition. For example, the United Kingdom has implemented restrictions that prohibit the use of reusable forceps in clinical settings.

This shift has constrained overall market value, as reusable devices contribute higher revenue per unit. Although disposables now dominate the market, their lower price points limit total market growth despite higher volumes.

Market Coverage and Data Scope

Quantitative Coverage

Market size, shares, and forecasts

Growth rates, units sold, and average selling prices

Qualitative Coverage

Market growth trends and limiters

Competitive analysis and SWOT for top competitors

Mergers and acquisitions, company profiles, and product portfolios

FDA recalls and disruptive technology developments

Disease overview and procedure data influencing demand

Time Frame

• Base year: 2025
• Forecasts: 2026-2032
• Historical data: 2022-2024

Data Sources

Primary interviews with endoscopists, industry experts, and market executives, supplemented by hospital procurement data, import and export databases, and iData Research's internal database.

Method Note

Revenue estimates are modeled from units multiplied by ASP, validated against procedure numbers, utilization patterns, and replacement cycles by region.

Markets Covered and Segmentation

• Biopsy Forceps & Polypectomy Snare Market - Further Segmented Into:

Biopsy Forceps

Polypectomy Snares

Competitive Analysis

Boston Scientific was the market leader in 2025, holding nearly half of the global biopsy forceps and polypectomy snare market. The company's success is largely attributed to the strength of its Radial Jaw product line, which remains one of the most widely used forceps families globally. Boston Scientific's consistent investment in product innovation and global distribution has solidified its leadership position across multiple regions.

Olympus Corporation maintained its presence through a portfolio of reusable biopsy forceps and snares. However, as demand for reusables continues to decline, Olympus has experienced gradual share erosion in recent years. The company remains most competitive in markets where reusable devices are still preferred, such as select European and Asian countries.

Cook Medical ranked as the third-largest competitor in the global market. The company offers a comprehensive product range that includes Captura Pro Biopsy Forceps, Captura Disposable Hot Biopsy Forceps, and Captura Mini Biopsy Forceps. Within the snare segment, Cook markets the AcuSnare Polypectomy Snare and its AcuSnare Duck Bill variant, known for their performance in capturing small and difficult polyps.

Overall, the market remains moderately consolidated, with these three manufacturers controlling the majority of global revenue. Smaller regional firms compete primarily in localized markets, often focusing on cost-competitive disposable offerings.

Technology and Practice Trends

The shift toward disposable biopsy forceps is now the dominant global trend, driven by infection prevention policies and lower reprocessing costs.

Cold snaring is replacing hot snaring and forceps resection for smaller polyps due to improved safety and margin clearance.

Single-use designs continue to improve in quality, offering comparable performance to reusable instruments at a fraction of the cost.

Ergonomic handles and improved jaw geometry are being introduced to enhance precision and reduce operator fatigue during extended procedures.

Training and procedural standardization efforts are increasing worldwide as endoscopy societies promote safe polypectomy and cold snare techniques.

Regulatory shifts in favor of disposables and infection control compliance continue to drive purchasing decisions in hospitals and clinics.

Geography

This edition provides complete global coverage, including data for North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

Methodology Appendix and Acronym Glossary

Why This Report

Where are the largest and fastest-growing opportunities within the global biopsy forceps and polypectomy snare market

How are pricing trends and disposable adoption shaping revenue growth across regions

What are the key risks and challenges, including declining reusable device sales and price competition

How will colorectal cancer screening programs influence demand for forceps and snares over the next decade

Which manufacturers are leading, and how are they positioning their product portfolios to compete globally

What technological and procedural shifts are redefining physician preferences in biopsy and polypectomy

The Global Biopsy Forceps & Polypectomy Snares Market Report from iData Research answers these questions with procedure-aware models, company share data, and price trend analysis. Use it to evaluate opportunities, benchmark performance, and plan product strategies in one of the most essential accessory markets in gastrointestinal endoscopy.

TABLE OF CONTENT

Table Of Contents

List Of Figures

List Of Charts

Research Methodology

• Step 1: Project Initiation & Team Selection
• Step 2: Prepare Data Systems And Perform Secondary Research
• Step 3: Preparation For Interviews & Questionnaire Design
• Step 4: Performing Primary Research
• Step 5: Research Analysis: Establishing Baseline Estimates
• Step 6: Market Forecast And Analysis
• Step 7: Identify Strategic Opportunities
• Step 8: Final Review And Market Release
• Step 9: Customer Feedback And Market Monitoring

Impact Of Global Tariffs

Biopsy Forceps And Polypectomy Snares Market

• 8.1 Executive Summary
  • 8.1.1 Global Biopsy Forceps & Polypectomy Snares Market Overview
  • 8.1.2 Competitive Analysis
  • 8.1.3 Procedure Segmentation
  • 8.1.4 Market Segmentation
  • 8.1.5 Regions Included
• 8.2 Introduction
• 8.3 Procedure Numbers
  • 8.3.1 Total Tissue Biopsy Procedures
  • 8.3.2 Biopsy Forceps Procedures
  • 8.3.3 Polypectomy Snare Procedures
• 8.4 Market Overview
  • 8.4.1 By Segment
  • 8.4.2 By Region
• 8.5 Market Analysis And Forecast
  • 8.5.1 Total Biopsy Forceps And Polypectomy Snares Market
  • 8.5.2 Biopsy Forceps Market
  • 8.5.3 Polypectomy Snare Market
• 8.6 Drivers And Limiters
  • 8.6.1 Market Drivers
  • 8.6.2 Market Limiters
• 8.7 Competitive Market Share Analysis

Abbreviations

LIST OF CHARTS

• Chart 8-1: Biopsy Forceps & Polypectomy Snares Market, Global, 2025 & 2032
• Chart 8-2: Biopsy Forceps & Polypectomy Snares Procedures, Global, 2025
• Chart 8-3: Tissue Biopsy Procedures by Segment, Global, 2022 - 2032
• Chart 8-4: Tissue Biopsy Procedures by Segment, Global, 2022 - 2032
• Chart 8-5: Biopsy Forceps & Polypectomy Snares Market by Segment, Global, 2022 - 2032
• Chart 8-6: Biopsy Forceps and Polypectomy Snares Market by Region, Global, 2022 - 2032
• Chart 8-7: Leading Competitors, Biopsy Forceps & Polypectomy Snares Market, Global, 2025

LIST OF FIGURES

• Figure 8-1: Biopsy Forceps & Polypectomy Snares Procedure Segmentation
• Figure 8-2: Biopsy Forceps & Polypectomy Snares Market Segmentation
• Figure 8-3: Biopsy Forceps & Polypectomy Snares Regions Covered, Global (1 of 2)
• Figure 8-4: Biopsy Forceps & Polypectomy Snares Regions Covered, Global (2 of 2)
• Figure 8-5: Tissue Biopsy Procedures by Segment, Global, 2022 - 2032
• Figure 8-6: Tissue Biopsy Procedures by Region, Global, 2022 - 2032
• Figure 8-7: Tissue Biopsy Procedures by Country, North America, 2022 - 2032
• Figure 8-8: Tissue Biopsy Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
• Figure 8-9: Tissue Biopsy Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
• Figure 8-10: Tissue Biopsy Procedures by Country, Western Europe, 2022 - 2032
• Figure 8-11: Tissue Biopsy Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
• Figure 8-12: Tissue Biopsy Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)
• Figure 8-13: Tissue Biopsy Procedures by Country, Middle East, 2022 - 2032
• Figure 8-14: Tissue Biopsy Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
• Figure 8-15: Tissue Biopsy Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
• Figure 8-16: Tissue Biopsy Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
• Figure 8-17: Tissue Biopsy Procedures by Country, Africa, 2022 - 2032
• Figure 8-18: Biopsy Forceps Procedures by Region, Global, 2022 - 2032
• Figure 8-19: Biopsy Forceps Procedures by Country, North America, 2022 - 2032
• Figure 8-20: Biopsy Forceps Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
• Figure 8-21: Biopsy Forceps Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
• Figure 8-22: Biopsy Forceps Procedures by Country, Western Europe, 2022 - 2032
• Figure 8-23: Biopsy Forceps Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
• Figure 8-24: Biopsy Forceps Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)
• Figure 8-25: Biopsy Forceps Procedures by Country, Middle East, 2022 - 2032
• Figure 8-26: Biopsy Forceps Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
• Figure 8-27: Biopsy Forceps Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
• Figure 8-28: Biopsy Forceps Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
• Figure 8-29: Biopsy Forceps Procedures by Country, Africa, 2022 - 2032
• Figure 8-30: Polypectomy Snare Procedures by Region, Global, 2022 - 2032
• Figure 8-31: Polypectomy Snare Procedures by Country, North America, 2022 - 2032
• Figure 8-32: Polypectomy Snare Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
• Figure 8-33: Polypectomy Snare Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
• Figure 8-34: Polypectomy Snare Procedures by Country, Western Europe, 2022 - 2032
• Figure 8-35: Polypectomy Snare Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
• Figure 8-36: Polypectomy Snare Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)
• Figure 8-37: Polypectomy Snare Procedures by Country, Middle East, 2022 - 2032
• Figure 8-38: Polypectomy Snare Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
• Figure 8-39: Polypectomy Snare Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
• Figure 8-40: Polypectomy Snare Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
• Figure 8-41: Polypectomy Snare Procedures by Country, Africa, 2022 - 2032
• Figure 8-42: Biopsy Forceps & Polypectomy Snares Market by Segment, Global, 2022 - 2032 (US$M)
• Figure 8-43: Biopsy Forceps and Polypectomy Snares Market by Region, Global, 2022 - 2032 (US$M)
• Figure 8-44: Biopsy Forceps and Polypectomy Snares Market, Global, 2022 - 2032
• Figure 8-45: Units Sold by Region, Biopsy Forceps and Polypectomy Snares Market, Global, 2022 - 2032
• Figure 8-46: Average Selling Price by Region, Biopsy Forceps and Polypectomy Snares Market, Global, 2022 - 2032 (US$)
• Figure 8-47: Market Value by Region, Biopsy Forceps and Polypectomy Snares Market, Global, 2022 - 2032 (US$M)
• Figure 8-48: Biopsy Forceps Market, Global, 2022 - 2032
• Figure 8-49: Units Sold by Region, Biopsy Forceps Market, Global, 2022 - 2032
• Figure 8-50: Average Selling Price by Region, Biopsy Forceps Market, Global, 2022 - 2032 (US$)
• Figure 8-51: Market Value by Region, Biopsy Forceps Market, Global, 2022 - 2032 (US$M)
• Figure 8-52: Polypectomy Snare Market, Global, 2022 - 2032
• Figure 8-53: Units Sold by Region, Polypectomy Snare Market, Global, 2022 - 2032
• Figure 8-54: Average Selling Price by Region, Polypectomy Snare Market, Global, 2022 - 2032 (US$)
• Figure 8-55: Market Value by Region, Polypectomy Snare Market, Global, 2022 - 2032 (US$M)
• Figure 8-56: Leading Competitors, Biopsy Forceps & Polypectomy Snares Market, Global, 2025